Oxalomalic acid (trisodium)
Oxalomalic acid (Oxalomalate) trisodium is a aconitase and NADP-dependent isocitrate dehydrogenase inhibitor. Oxalomalic acid trisodium inhibits nitrite production and iNOS protein expression in lipopolysaccharide -activated J774 macrophages[1].
Product Specifications
CAS Number
89304-26-7
Product Name Alternative
Oxalomalate (trisodium)
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Isocitrate Dehydrogenase (IDH)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/oxalomalic-acid-trisodium.html
Purity
95.0
Solubility
H2O : 1 mg/mL (ultrasonic; warming)
Smiles
O=C(C(C(C(C(O[Na])=O)O)C(O[Na])=O)=O)O[Na]
Molecular Formula
C6H3Na3O8
Molecular Weight
272.05
Precautions
H302, H315, H319, H335
References & Citations
[1]Irace C, et al. Oxalomalate affects the inducible nitric oxide synthase expression and activity. Life Sci. 2007 Mar 13;80 (14) :1282-91.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Histone H1 (AE-4), CF640R conjugate, 0.1mg/mL
MUC18 / Mucin 18 / CD146 (OJ79c), CF488A conjugate, 0.1mg/mL
Insulin (2D11-H5), CF488A conjugate, 0.1mg/mL
